Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
37.40
-0.20 (-0.53%)
At close: Oct 2, 2026, 4:00 PM EDT
37.34
-0.06 (-0.16%)
After-hours: Oct 2, 2026, 7:30 PM EDT
Definium Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LifeSci Capital | LifeSci Capital | Buy Maintains $78 | Buy | Maintains | $78 | +108.56% | Sep 19, 2026 |
| Maxim Group | Maxim Group | Buy Maintains $55 | Buy | Maintains | $55 | +47.06% | Sep 16, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $60 → $67 | Buy | Maintains | $60 → $67 | +79.14% | Sep 16, 2026 |
| JonesTrading | JonesTrading | Buy Reiterates $90 | Buy | Reiterates | $90 | +140.64% | Sep 15, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $64 → $78 | Buy | Reiterates | $64 → $78 | +108.56% | Sep 15, 2026 |
| Robert W. Baird | Robert W. Baird | Buy Maintains $75 → $79 | Buy | Maintains | $75 → $79 | +111.23% | Sep 15, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $70 → $75 | Buy | Maintains | $70 → $75 | +100.53% | Sep 14, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $75 → $91 | Buy | Reiterates | $75 → $91 | +143.32% | Sep 14, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.